Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Isis presents new antisense oligonucleotides for cancer

Feb. 27, 2001

AN-207 selectively targets LHRH receptor-expressing ovarian cancer cells

Feb. 27, 2001

CA4P exerts antiangiogenic effects in animal lymphoma model

Feb. 27, 2001

Microbial metabolite inhibits interaction between p53 and MDM2

Feb. 27, 2001

Antitumor effects of salvicine related to its ability to induce apoptosis

Feb. 26, 2001

SR-7 disrupts G2/M transition via an apparently novel mechanism of action

Feb. 26, 2001

Enrollment complete in pivotal trial of IM-862 in AIDS-related Kaposi's sarcoma

Feb. 26, 2001

MedImmune and Targesome establish agreement for Vitaxin development

Feb. 26, 2001

Interim data from phase II mucositis trial presented by Access

Feb. 26, 2001

Texas university researchers identify PEA3 as a tumor suppressor for cancer treatment

Feb. 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...